Roche China Ltd.
Industry / private company
Location:
Shanghai,
China (CN)
ISNI: 0000000417590967
ROR: https://ror.org/02hv5e369
KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer (2019)
Mamounas EP, Geyer CE, Huang CS, Mano MS, Loibl S, Untch M, Wolmark N, et al.
Conference contribution
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer (2019)
Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, et al.
Journal article